ZA855552B - Amidine compounds - Google Patents
Amidine compoundsInfo
- Publication number
- ZA855552B ZA855552B ZA855552A ZA855552A ZA855552B ZA 855552 B ZA855552 B ZA 855552B ZA 855552 A ZA855552 A ZA 855552A ZA 855552 A ZA855552 A ZA 855552A ZA 855552 B ZA855552 B ZA 855552B
- Authority
- ZA
- South Africa
- Prior art keywords
- amidine compounds
- amidine
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15504584A JPS6133173A (ja) | 1984-07-25 | 1984-07-25 | アミジン化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA855552B true ZA855552B (en) | 1986-03-26 |
Family
ID=15597463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA855552A ZA855552B (en) | 1984-07-25 | 1985-07-23 | Amidine compounds |
Country Status (19)
Country | Link |
---|---|
US (2) | US4777182A (xx) |
EP (1) | EP0190356B1 (xx) |
JP (1) | JPS6133173A (xx) |
KR (2) | KR870001087B1 (xx) |
AU (1) | AU567039B2 (xx) |
CA (1) | CA1254205A (xx) |
CS (1) | CS255891B2 (xx) |
DD (1) | DD235637A5 (xx) |
DE (1) | DE3582057D1 (xx) |
DK (1) | DK169069B1 (xx) |
ES (1) | ES8607218A1 (xx) |
FI (1) | FI78461C (xx) |
HU (1) | HU195769B (xx) |
MX (1) | MX160912A (xx) |
NO (1) | NO163954C (xx) |
PH (1) | PH20585A (xx) |
SU (1) | SU1456008A3 (xx) |
WO (1) | WO1986000893A1 (xx) |
ZA (1) | ZA855552B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3824236C1 (xx) * | 1988-07-16 | 1989-12-28 | Heidelberger Druckmaschinen Ag, 6900 Heidelberg, De | |
CA2032420A1 (en) * | 1989-12-22 | 1991-06-23 | Akira Okuyama | Guanidinobenzene derivatives |
US5238964A (en) * | 1990-04-05 | 1993-08-24 | Torii & Co., Ltd. | Agent for treatment of cerebrovascular contraction |
US5652237A (en) * | 1994-09-09 | 1997-07-29 | Warner-Lambert Company | 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes |
ATE222583T1 (de) * | 1995-01-05 | 2002-09-15 | Torii Pharmaceutical Co Ltd | Derivate substituierter amidinonaphthylester |
US5932603A (en) * | 1995-01-05 | 1999-08-03 | Torii Pharmaceutical Co., Ltd. | Thrombolytic agents |
CA2320900C (en) | 1998-03-19 | 2009-10-27 | Bristol-Myers Squibb Company | Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
WO2001077082A1 (fr) * | 1999-06-02 | 2001-10-18 | Torii Pharmaceutical Co., Ltd. | Derives de naphtalene |
WO2001094299A1 (fr) * | 2000-06-08 | 2001-12-13 | Shizuoka Coffein Co., Ltd. | Derives de benzene |
WO2006123675A1 (ja) * | 2005-05-17 | 2006-11-23 | Santen Pharmaceutical Co., Ltd. | アミジノ誘導体を有効成分として含む神経細胞の保護剤 |
EP1884236B1 (en) * | 2005-05-17 | 2011-03-02 | Santen Pharmaceutical Co., Ltd. | Angiogenesis inhibitor containing amine derivative as active ingredient |
WO2008058167A2 (en) * | 2006-11-07 | 2008-05-15 | Case Western Reserve University | Method for treating disorders associated with complement activation |
MX342120B (es) | 2010-07-09 | 2016-09-14 | William Owen Wilkison | Combinación de sistema de liberación prolongada/inmediata para productos farmacéuticos de vida media corta como el remogliflozin. |
JP6252991B2 (ja) * | 2012-07-04 | 2017-12-27 | 味の素株式会社 | ナファモスタットメシル酸塩の製造方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4292429A (en) * | 1978-03-08 | 1981-09-29 | Ciba-Geigy Corporation | Imidazole urea and amido compounds |
JPS57179146A (en) * | 1981-04-28 | 1982-11-04 | Torii Yakuhin Kk | Amidine compound |
AU527371B2 (en) * | 1980-09-16 | 1983-03-03 | Torii & Co., Ltd. | Amidine |
JPS60130561A (ja) * | 1983-12-16 | 1985-07-12 | Torii Yakuhin Kk | アミジン誘導体およびそれを含む強心剤 |
-
1984
- 1984-07-25 JP JP15504584A patent/JPS6133173A/ja active Granted
-
1985
- 1985-07-12 DE DE8585903394T patent/DE3582057D1/de not_active Expired - Fee Related
- 1985-07-12 HU HU853727A patent/HU195769B/hu not_active IP Right Cessation
- 1985-07-12 AU AU45492/85A patent/AU567039B2/en not_active Ceased
- 1985-07-12 EP EP85903394A patent/EP0190356B1/en not_active Expired - Lifetime
- 1985-07-12 CA CA000486773A patent/CA1254205A/en not_active Expired
- 1985-07-12 US US06/835,853 patent/US4777182A/en not_active Expired - Fee Related
- 1985-07-12 WO PCT/JP1985/000392 patent/WO1986000893A1/ja active IP Right Grant
- 1985-07-12 KR KR1019860700140A patent/KR870001087B1/ko active
- 1985-07-23 PH PH32559A patent/PH20585A/en unknown
- 1985-07-23 ES ES545482A patent/ES8607218A1/es not_active Expired
- 1985-07-23 DD DD85278877A patent/DD235637A5/de not_active IP Right Cessation
- 1985-07-23 ZA ZA855552A patent/ZA855552B/xx unknown
- 1985-07-24 CS CS855463A patent/CS255891B2/cs not_active IP Right Cessation
- 1985-07-24 MX MX206081A patent/MX160912A/es unknown
-
1986
- 1986-03-03 DK DK096286A patent/DK169069B1/da not_active IP Right Cessation
- 1986-03-04 FI FI860904A patent/FI78461C/fi not_active IP Right Cessation
- 1986-03-07 NO NO86860865A patent/NO163954C/no not_active IP Right Cessation
- 1986-03-10 KR KR1019860700140A patent/KR860700250A/ko not_active IP Right Cessation
- 1986-03-24 SU SU864027333A patent/SU1456008A3/ru active
-
1988
- 1988-07-11 US US07/217,405 patent/US4820730A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU4549285A (en) | 1986-02-25 |
JPS6133173A (ja) | 1986-02-17 |
ES545482A0 (es) | 1986-05-16 |
EP0190356B1 (en) | 1991-03-06 |
NO163954C (no) | 1990-08-15 |
MX160912A (es) | 1990-06-14 |
JPH0461868B2 (xx) | 1992-10-02 |
FI78461C (fi) | 1989-08-10 |
CA1254205A (en) | 1989-05-16 |
WO1986000893A1 (en) | 1986-02-13 |
HUT42433A (en) | 1987-07-28 |
CS546385A2 (en) | 1987-07-16 |
CS255891B2 (en) | 1988-03-15 |
FI78461B (fi) | 1989-04-28 |
HU195769B (en) | 1988-07-28 |
NO860865L (no) | 1986-04-10 |
KR860700250A (ko) | 1986-08-01 |
ES8607218A1 (es) | 1986-05-16 |
AU567039B2 (en) | 1987-11-05 |
NO163954B (no) | 1990-05-07 |
FI860904A (fi) | 1986-03-04 |
EP0190356A1 (en) | 1986-08-13 |
US4777182A (en) | 1988-10-11 |
DK169069B1 (da) | 1994-08-08 |
DD235637A5 (de) | 1986-05-14 |
SU1456008A3 (ru) | 1989-01-30 |
DK96286D0 (da) | 1986-03-03 |
PH20585A (en) | 1987-02-20 |
KR870001087B1 (ko) | 1987-06-04 |
US4820730A (en) | 1989-04-11 |
DE3582057D1 (en) | 1991-04-11 |
DK96286A (da) | 1986-03-03 |
FI860904A0 (fi) | 1986-03-04 |
EP0190356A4 (en) | 1987-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2134901B (en) | Amidine compounds | |
DE3569932D1 (en) | Cotelomer compounds | |
GB8404584D0 (en) | Compounds | |
GB8404586D0 (en) | Compounds | |
GB8419797D0 (en) | Compounds | |
ZA855552B (en) | Amidine compounds | |
GB8415540D0 (en) | Imidazoisoquinoline compounds | |
GB8415377D0 (en) | Compounds | |
GB8406689D0 (en) | Compounds | |
GB8402086D0 (en) | Compounds | |
GB8412862D0 (en) | Compounds | |
GB8419103D0 (en) | Compounds | |
GB2162171B (en) | Amidine compounds | |
GB8401868D0 (en) | Compounds | |
GB8404047D0 (en) | Compounds | |
GB8409699D0 (en) | Compounds | |
GB8403463D0 (en) | Compounds | |
GB8403464D0 (en) | Compounds | |
GB8403003D0 (en) | Compounds | |
GB8402300D0 (en) | Schistosomicidal compounds | |
GB8411560D0 (en) | Compounds | |
GB8402089D0 (en) | Compounds | |
GB8404587D0 (en) | Compounds | |
GB8404588D0 (en) | Compounds | |
GB8405955D0 (en) | Compounds |